A Novel Sperm Selection Method Provides Advantages Over Conventional Approaches

NCT ID: NCT06545318

Last Updated: 2024-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

115 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to know if a novel sperm selection device (CA0) has a similar performance than the standard selection method in teratozoospermic and azoospermic men. The main questions it aims to answer are:

Does the CA0 sperm selection device increases the sperm concentration? Does the CA0 sperm selection device increases the sperm motility? What are the differences in sperm membrane potential when CA0 is used? Do intracellular Calcium levels change when CA0 is used? Does CA0 increase fertilization rates? Researchers will compare CA0 to the standard of care for sperm selection (density gradient centrifugation) to see if CA0 has similar performance

Participants will:

Provide a semen sample Have their semen sample analyzed, processed and used for assisted reproduction technologies

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Male Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
Participants did not know if their sperm would be selected by density gradient centrifugation ir the novel device (CA0 chamber)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Density Gradient Centrifugation

A density gradient of is formed in 15 mL conical tubes as follows: 1 mL of lower gradient (90%) medium is placed at the bottom, 1 mL of upper (45%) gradient medium is placed on top of the bottom layer, and 1 mL of semen sample is layered above the gradient. Tubes are centrifuged for 10 minutes at 1,200 x g at room temperature. The pellet containing the viable cells is separated, resuspended in 1 mL of HTF-HEPES medium, and centrifuged at room temperature for 10 minutes at 1,200 x g to remove traces of gradient medium. The supernatant is then removed, 500 µL of HTF-HEPES medium are added to the sperm pellet, carefully mixed, and cells are counted

Group Type ACTIVE_COMPARATOR

Density Gradient Centrifugation

Intervention Type DEVICE

Sperm separation with density gradients

CA0 chamber

One mL of semen is placed in the base, then the intermediate part is placed on the base, taking care to match the notches that assemble both parts. Subsequently, 900 µL of HTF-HEPES medium are placed in the intermediate part, the cover is placed and the device is incubated at 37°C for 30 minutes. Subsequently, a 500-µL aliquot is recovered and cells are counted

Group Type EXPERIMENTAL

CA0 chamber

Intervention Type DEVICE

Sperm separation with a novel device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Density Gradient Centrifugation

Sperm separation with density gradients

Intervention Type DEVICE

CA0 chamber

Sperm separation with a novel device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normozoospermic (18-35 years old) and teratozoospermic (18-60 years old) patients undergoing IVF/ICSI cyles with at least 2 days of sexual abstinence

Exclusion Criteria

* Less than 4 oocytes collected during oocyte retrieval
* Total sperm count less than 30x10\^6
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Nacional Autonoma de Mexico

OTHER

Sponsor Role collaborator

Center of Innovation Technology & Reproductive Medicine

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Liliana Berenice Ramírez Domínguez

Scientific Coordinator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudia L Treviño

Role: PRINCIPAL_INVESTIGATOR

Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología (IBT), Universidad Nacional Autónoma de México (UNAM), Cuernavaca, Morelos, México

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CITMER

Mexico City, , Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

References

Explore related publications, articles, or registry entries linked to this study.

Allamaneni SS, Agarwal A, Rama S, Ranganathan P, Sharma RK. Comparative study on density gradients and swim-up preparation techniques utilizing neat and cryopreserved spermatozoa. Asian J Androl. 2005 Mar;7(1):86-92. doi: 10.1111/j.1745-7262.2005.00008.x.

Reference Type BACKGROUND
PMID: 15685358 (View on PubMed)

Babcock DF. Examination of the intracellular ionic environment and of ionophore action by null point measurements employing the fluorescein chromophore. J Biol Chem. 1983 May 25;258(10):6380-9.

Reference Type BACKGROUND
PMID: 6853488 (View on PubMed)

Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011 Jun;26(6):1270-83. doi: 10.1093/humrep/der037. Epub 2011 Apr 18.

Reference Type BACKGROUND
PMID: 21502182 (View on PubMed)

Brown SG, Publicover SJ, Mansell SA, Lishko PV, Williams HL, Ramalingam M, Wilson SM, Barratt CL, Sutton KA, Da Silva SM. Depolarization of sperm membrane potential is a common feature of men with subfertility and is associated with low fertilization rate at IVF. Hum Reprod. 2016 Jun;31(6):1147-57. doi: 10.1093/humrep/dew056. Epub 2016 Apr 6.

Reference Type BACKGROUND
PMID: 27052499 (View on PubMed)

Chen MJ, Bongso A. Comparative evaluation of two density gradient preparations for sperm separation for medically assisted conception. Hum Reprod. 1999 Mar;14(3):759-64. doi: 10.1093/humrep/14.3.759.

Reference Type BACKGROUND
PMID: 10221710 (View on PubMed)

Farland LV, Khan SM, Missmer SA, Stern D, Lopez-Ridaura R, Chavarro JE, Catzin-Kuhlmann A, Sanchez-Serrano AP, Rice MS, Lajous M. Accessing medical care for infertility: a study of women in Mexico. F S Rep. 2022 Nov 24;4(1):112-120. doi: 10.1016/j.xfre.2022.11.013. eCollection 2023 Mar.

Reference Type BACKGROUND
PMID: 36959957 (View on PubMed)

Henkel RR, Schill WB. Sperm preparation for ART. Reprod Biol Endocrinol. 2003 Nov 14;1:108. doi: 10.1186/1477-7827-1-108.

Reference Type BACKGROUND
PMID: 14617368 (View on PubMed)

Hernandez-Silva G, Lopez-Torres AS, Maldonado-Rosas I, Mata-Martinez E, Larrea F, Torres-Flores V, Trevino CL, Chirinos M. Effects of Semen Processing on Sperm Function: Differences between Swim-Up and Density Gradient Centrifugation. World J Mens Health. 2021 Oct;39(4):740-749. doi: 10.5534/wjmh.200115. Epub 2020 Nov 19.

Reference Type BACKGROUND
PMID: 33474848 (View on PubMed)

Highland HN, Rishika AS, Almira SS, Kanthi PB. Ficoll-400 density gradient method as an effective sperm preparation technique for assisted reproductive techniques. J Hum Reprod Sci. 2016 Jul-Sep;9(3):194-199. doi: 10.4103/0974-1208.192070.

Reference Type BACKGROUND
PMID: 27803588 (View on PubMed)

Hsu CT, Lee CI, Lin FS, Wang FZ, Chang HC, Wang TE, Huang CC, Tsao HM, Lee MS, Agarwal A. Live motile sperm sorting device for enhanced sperm-fertilization competency: comparative analysis with density-gradient centrifugation and microfluidic sperm sorting. J Assist Reprod Genet. 2023 Aug;40(8):1855-1864. doi: 10.1007/s10815-023-02838-4. Epub 2023 Jun 10.

Reference Type BACKGROUND
PMID: 37300647 (View on PubMed)

Matamoros-Volante A, Castillo-Viveros V, Torres-Rodriguez P, Trevino MB, Trevino CL. Time-Lapse Flow Cytometry: A Robust Tool to Assess Physiological Parameters Related to the Fertilizing Capability of Human Sperm. Int J Mol Sci. 2020 Dec 24;22(1):93. doi: 10.3390/ijms22010093.

Reference Type BACKGROUND
PMID: 33374265 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CI-21-101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.